The Professional Home for Oncology Nurses

Even physical activity levels below current recommendations are associated with lower cancer mortality in survivors of certain cancers, researchers reported in the February 2026 issue of JAMA Network Open. The mortality benefit increased with greater levels of physical activity, highlighting the importance of exercise in maintaining health and longevity in cancer survivors.

Blinatumomab (Blincyto^®) is a bispecific T-cell engager used to treat certain types of B-cell acute lymphoblastic leukemia (ALL). It works by connecting the patient’s own T cells to leukemia cells, helping the immune system recognize and destroy cancer cells.

Funding and support from comprehensive cancer centers helps parks and recreation departments implement and maintain educational and infrastructure interventions for sun safety and physical activity, even after funding ends, study authors wrote in the February 2026 issue of Cancer Control.

On June 12, 2026, the U.S. Food and Drug Administration (FDA) approved capivasertib (Truqap^™) in combination with abiraterone and prednisone for adults with metastatic androgen pathway modulation-naïve or -sensitive (mAPMN/S) prostate cancer (previously referred to as metastatic hormone-sensitive prostate cancer) that is PTEN deficient as detected by an FDA-authorized test.

From Reuters.com: Revolution Medicine’s experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some patients could resume activities they had previously abandoned, setting a new benchmark for this deadly cancer, researchers reported on May 31, 2026.

Full results of the 500-person trial, which tested the once-daily pill against standard chemotherapy in patients whose cancer had failed one round of chemotherapy, showed that daraxonrasib reduced the overall risk of death by 60% compared with patients with advanced pancreatic cancer treated with chemotherapy.

The field of oncology is constantly changing, but one innovation in particular has transformed the way we approach cancer.